Lv4
460 积分 2025-06-25 加入
Dual antithrombotic therapy for atrial fibrillation and PCI
8个月前
已完结
The optimal duration of triple antithrombotic therapy in patients with atrial fibrillation and acute coronary syndrome or undergoing percutaneous coronary intervention: A network meta-analysis of randomized clinical trials
8个月前
已完结
Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention
8个月前
已完结
Safety and efficacy outcomes of double vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and meta-analysis of non-vitamin K antagonist oral anticoagulant-based randomized clinical trials
8个月前
已完结
Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial
8个月前
已完结
Antithrombotic Strategies in Atrial Fibrillation After ACS and/or PCI: A 4-Way Comparison From AUGUSTUS
8个月前
已完结
Antithrombotic Therapy to Minimize Total Events After ACS or PCI in Atrial Fibrillation
8个月前
已完结
Rationale and Design of the H-REPLACE Study: Safety and Efficacy of LMWH Versus Rivaroxaban in ChinEse Patients HospitaLized with Acute Coronary SyndromE
8个月前
已完结
Post-discharge pharmacotherapy in people with atrial fibrillation hospitalized for acute myocardial infarction: an Australian cohort study 2018–22
8个月前
已完结
A network meta-analysis of direct oral anticoagulants for portal vein thrombosis in cirrhosis
10个月前
已完结
皖公网安备34019202002308
